Cybin Inc (AMEX: CYBN) has experienced a decline in its stock price by -4.93 compared to its previous closing price of 9.53. However, the company has seen a fall of -4.23% in its stock price over the last five trading days. businesswire.com reported 2024-12-10 that TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced the presentation of two posters at the American College of Neuropsychopharmacology (“ACNP”) Annual Meeting taking place December 8-11, 2024, in Phoenix, Arizona. The data presented include 12-month efficacy result.
Is It Worth Investing in Cybin Inc (AMEX: CYBN) Right Now?
There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CYBN is 18.44M, and at present, short sellers hold a 3.55% of that float. The average trading volume of CYBN on December 27, 2024 was 343.51K shares.
CYBN’s Market Performance
The stock of Cybin Inc (CYBN) has seen a -4.23% decrease in the past week, with a -14.85% drop in the past month, and a -8.30% fall in the past quarter. The volatility ratio for the week is 4.59%, and the volatility levels for the past 30 days are at 5.45% for CYBN. The simple moving average for the past 20 days is -9.33% for CYBN’s stock, with a -20.40% simple moving average for the past 200 days.
CYBN Trading at -13.06% from the 50-Day Moving Average
After a stumble in the market that brought CYBN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.36% of loss for the given period.
Volatility was left at 5.45%, however, over the last 30 days, the volatility rate increased by 4.59%, as shares sank -15.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.40% lower at present.
During the last 5 trading sessions, CYBN fell by -4.23%, which changed the moving average for the period of 200-days by -45.81% in comparison to the 20-day moving average, which settled at $9.99. In addition, Cybin Inc saw -41.85% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CYBN
The total capital return value is set at -0.53. Equity return is now at value -80.93, with -76.72 for asset returns.
Currently, EBITDA for the company is -78.58 million with net debt to EBITDA at 1.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 24.24.
Conclusion
In summary, Cybin Inc (CYBN) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
